Reducing the Peptidyl Features of Caspase-3 Inhibitors: A Structural Analysis.
Becker, J.W., Rotonda, J., Soisson, S.M., Aspiotis, R., Bayly, C., Francoeur, S., Gallant, M., Garcia-Calvo, M., Giroux, A., Grimm, E., Han, Y., McKay, D., Nicholson, D.W., Peterson, E., Renaud, J., Roy, S., Thornberry, N., Zamboni, R.(2004) J Med Chem 47: 2466-2474
- PubMed: 15115390 
- DOI: 10.1021/jm0305523
- Primary Citation of Related Structures:  
1RE1, 1RHM, 1RHK, 1RHJ, 1RHU, 1RHR, 1RHQ - PubMed Abstract: 
Caspases are cysteine proteases that specifically cleave Asp-Xxx bonds. They are key agents in inflammation and apoptosis and are attractive targets for therapy against inflammation, neurodegeneration, ischemia, and cancer. Many caspase structures are known, but most involve either peptide or protein inhibitors, unattractive candidates for drug development ...